Medical research

Cancer drug lessens the toxicity of a protein from COVID-19 virus

University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2—the virus that causes COVID-19—and then used an FDA-approved cancer drug to blunt the viral protein's ...

Health

NIDA: Teen vaping levels seem to have plateaued in 2020

(HealthDay)—Teen vaping levels remained high in 2020 but have not increased substantially since 2019, according to results from the annual Monitoring the Future survey, which is funded by the National Institute on Drug ...

Medical research

Protein twist and squeeze confers cancer drug resistance

In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), discovered that a protein called ABCB1 could transport multiple chemotherapeutics out of ...

Diseases, Conditions, Syndromes

Treatment of chloroquine poisoning

Research by Bangor University's Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19.

Medical research

New drug leads could battle brain-eating amoebae

Brain-eating amoebae can cause particularly harmful forms of encephalitis, and more than 95% of people who develop these rare but devastating infections die. Despite the high mortality rate, there is currently no single effective ...

Oncology & Cancer

Potential upgrades on in vitro toxicological cell-based models

Over the last 100 years, knowledge regarding drug toxicity has increased significantly, especially since the thalidomide tragedy of the mid-20th century. This tragedy marked the beginning of rigorous drug approval and monitoring ...

page 4 from 16